Initial experience of combined immunosuppressive induction therapy with polyclonal antithymocyte antibody, FK 506 (tacrolimus), and prednisolone in clinical liver transplantation

Transplant Proc. 2000 Dec;32(8):2817-9. doi: 10.1016/s0041-1345(00)01895-9.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Aged
  • Antilymphocyte Serum / therapeutic use*
  • Drug Therapy, Combination
  • Follow-Up Studies
  • Humans
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / blood
  • Immunosuppressive Agents / therapeutic use*
  • Liver Transplantation / immunology*
  • Middle Aged
  • Postoperative Complications / epidemiology
  • Prednisolone / therapeutic use*
  • Prospective Studies
  • Tacrolimus / blood
  • Tacrolimus / therapeutic use*
  • Time Factors

Substances

  • Antilymphocyte Serum
  • Immunosuppressive Agents
  • Prednisolone
  • Tacrolimus